Company Liquidation LTD

Company profile

Pneumowave Limited

UK company SC589011, incorporated on 16 February 2018.

Home - PneumoWave

PneumoWave aims to transform the way patients with respiratory conditions manage their health and live their lives. Contact us to learn more!

Company number
SC589011
Incorporated
16 Feb 2018
Companies House status
Liquidation

Company identity

Founded / incorporated
16 February 2018

Company number SC589011

Verify at Companies House
Legal name
PNEUMOWAVE LIMITED
Company type
Private Limited Company
Region
Scotland
Registered address
C/O FRP ADVISORY TRADING LIMITED APEX 3
95 HAYMARKET TERRACE
EDINBURGH
EH12 5HD
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 1
1
Company Liquidation LTD
Pneumowave Limited
CRN SC589011
2
Direct and ultimate controller Active PLC

Company events

Reference milestones and recent Companies House filing stream events.

5 events
21 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts due

Accounts Due

Next accounts due date

07 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2023

Accounts filed

Accounts

Last accounts made up date

16 Feb
2018

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2018
Funded years
2018, 2023
Age at first award
0 years

Projects

2023 Collaborative R&D Lead participant

Advances in precision medicine for paediatric sleep disorders - Paediatric Advanced Respiratory Service (PARS) study

1 Sep 2023 to 31 Aug 2025

Awarded
£455,510
Total cost £650,728

This project aims to address an unmet need in paediatric respiratory and sleep diagnostics. It focuses on the development of PneumoWave's novel respiratory monitoring platform which will be tailored specifically for children. It combines wireless wearable biosensors, mobile 'App'-based software and Artificial Intelligence for non-invasive monitoring, enab...

2018 Feasibility Studies Lead participant

Toxicity Alert Biosensor (TAB)

1 Dec 2018 to 31 May 2019

Awarded
£125,114
Total cost £178,735

"Opioids are a class of drug prescribed for pain relief or used illicitly for their euphoric effect. In 2016, 23 million prescriptions were issued for opioids in the UK. In that same year, 2,893 people died from accidental opioid overdose. In the USA, there were more than 42,000 deaths. Opioid overdose is now the largest cause of accidental death in most ...

Product types

Collaborative R&D Feasibility Studies